Upcoming Events

View More...

Join the world’s largest meeting of non-alcoholic steatohepatitis stakeholders at industry’s most comprehensive NASH drug development conference: the 3rd Annual NASH Summit (April 22-25 2019, Boston, MA).

Across 4 days of focused seminars and parallel learning tracks, the 3rd Annual NASH Summit will cover every element of NASH drug development from early discovery to late-stage clinical development and commercialization. Providing an unparalleled learning and networking experience; this exclusive forum is the unrivaled opportunity to network with 300 drug developers from 140 organizations and accelerate the development of your NASH candidate pipeline.

View Less

View More...

Pharmacology 2019 focuses on the importance to understand drugs and how they can affect human physiology. It is with better understanding of Pharmacology one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction between drug and its therapeutic effect helps to identify the properties of ideal drugs.

 

The Conference provides the research work of pharmacology and therapeutics from various scientific backgrounds and the same can be perceived by pharmacologists, scientists and students. Pharmacology 2019 brings unique platform for scientists, researchers, academicians, professors and students to share their knowledge and views also presenting research about latest pharmacological activities of drugs and chemical properties. PULSUS Group provides an opportunistic environment and vibrant podium through these auspicious events.

View Less

View More...

EUROSCICON is buoyant to proclaim the launch of “23rd Edition of International Conference on Neonatology and Perinatology” in London, UK from April 23-24, 2019.

Neonatology 2019 symposium targets the undiscovered phases of neonatal and perinatal research which gives an inimitable chance to researchers all over the world to participate, share and perceive new thoughts and also exploration work. Our theme “Devising modern techniques to improve Neonatal health” focuses on understanding the unknown facts of the neonatology, perinatology and its research. The three day conference embraces the workshops and keynote speech from some prominent researchers who outshine in the field of focus. This conference comprises the matters of neonatology such as Neonatal Jaundice, infant respiratory distress syndrome, Neonatal conjunctivitis, Neonatal stroke and many more. Our international conference also inspires the involvement of students, impending researches as we are compering Young research Forum and best poster award at our conference.

View Less

View More...

The 3rd Annual European NeoAg Summit is the leading industry-dedicated meeting focused on advancing personalised cancer immunotherapy through neoantigen targeting. Over the last year, there has been a record number of neoantigen-based therapies heading into and through the clinic. In addition, exciting collaborations that bring significant investment into the space means that tumour-specific antigen targeting is set to explode. At the European NeoAg Summit, we bring together the leading pharma and biotech companies to discuss:

•  Reducing the discordance between various neoantigen prediction methods
•  Maximising the immune response to neoantigens
•  Shortening the needle-to-needle time of personalised cancer immunotherapy
•  Navigating the evolving regulatory landscape to faster approval

View Less

View More...

Over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, alternative scaffolds, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.

Including 6 interactive streams:

    Protein Engineering, Design & Selection
    Bioconjugates – ADC And Protein Fusion Therapeutics – Engineering, Safety And Clinical Considerations for Therapeutic Innovation
    Antibody Engineering, Design & Development
    Cloning, Expression & Purification, Crispr and Cell Engineering
    Biotherapeutics: Manufacturing, Chemistry, Analytics and Control
    Protein & Antibody Biotherapeutic Development Including Immuno-Oncology and Car T Cell Therapy

View Less

View More...

Over 450 peptides, proteins and antibodies attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

Over 25 presentations and case studies focused on the key advancements in peptide development, therapeutics and formulation, delivery and manufacturing.

Two-day interactive conference addressing three main themes:

    Peptide Discovery, Chemistry and Analytical Technologies
    Peptide Therapeutics
    Peptide Delivery and Formulation

View Less

View More...

Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics

Two-day interactive conference addressing the following topics:

    Market Access Strategies, Opportunities and Commercial Challenges
    Developing Biosimilars and Biobetters – Clinical Development, Manufacturing and Bio-Analytics

View Less

View More...

The Saudi International Health Insurance Congress, taking place on 29 April – 01 May 2019, is a strategic platform to meet and hear from top notch leaders, policy and decision makers from all over the region who will share and exchange their views and experiences over the development of health insurance in the region; the opportunities and challenges of implementing a unified medical record; a look into global healthcare trends on connected health and data technologies shaping the future growth of health insurance industry; examine rejection rates, fraud and abuse in the health insurance system; strengthen payer and provider partnerships; regulate pricing and medical inflation; and the emerging role of employers and patients in the mandatory health coverage. All these and more will be deliberated through an inspiring mix of interactive panel discussions, case studies, and session presentations.

View Less

View More...

CRAACO is guided by a dedicated group of advisors from pharma, healthcare, patients and patient advocacy who are passionate about providing patients with the best possible options. With four years of experience gathering the clinical research and healthcare communities together, CRAACO has the most experience addressing the value, opportunities, and challenges to integrating clinical research as a care option for the benefit of patients.

 

View Less

View More...

The GCC healthcare environment is rapidly changing and flourishing with unprecedented demand in healthcare services. With the total healthcare spending expected to reach $60 billion by 2025, there is no doubt that the healthcare sector in the region would have never reached this point without adopting up-to-date innovate strategies, and of course technologies.

 

But for GCC countries, such demands are faced with great challenges, complicated by high growth rate of population, increasing chronic diseases, shortage of qualified healthcare professionals and transitions in healthcare systems. All these demands and challenges will require the development of healthcare policies and innovative strategies to effectively achieve an efficient delivery of healthcare to the people.

 

That’s why the 6th GCC Healthcare Innovation Congress is coming back this year to highlight on the most imperative themes which focus on utilising the best of technology to improve flow and clinical decisions, while reducing waste and minimising cost in the healthcare sector, aiming towards one end result that is high quality patient care.

View Less

View More...

CBI’s 6th Annual FMV Congress promotes a deeper understanding of the risk factors when establishing compliant FMV programs and processes within the life sciences industry. This comprehensive conference addresses critical challenges in harmonizing clinical and post-approval FMV practices, strategizing for success with bona fide fee-for-service agreements, and keeping up with evolving requirements and regulations related to FMV. This forum also provides an opportunity to benchmark against your peers, learn about FMV best practices and participate in interactive and compelling discussions with industry experts

View Less

View More...

The 2nd annual Drug Delivery West (DDW) Summit provides a west coast venue for biotech, pharma and drug delivery companies to address scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care.

View Less

View Less

View More...

Chronic Kidney Disease Drug Development (CKD3) focuses exclusively on overcoming challenges limiting the development of more efficacious and disease-modifying drugs against diabetic nephropathy, genetic and glomerular kidney disease.

 

Incorporating insights from 32 world class experts including regulatory updates from the FDA, and analysis of the results from CREDENCE by Janssen R&D; this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs.

 

Join 100 of your colleagues to accelerate the development and clinical validity of SGLT-2 inhibitors, antagonists of renal fibrosis and much more.

View Less

View More...

PREDiCT’s 3D Oncology Summit is all about showcasing the impact 3D models are having on IO and Oncology pipelines.

 

2018’s inaugural event saw over 80 leading scientists from 50+ different model-development and pharmaceutical organizations meet to define core criteria for the use of 3D tumor models.

 

This year, alongside fresh new case studies and speakers, discussions will address open questions to translatability, platform validity, alongside how additive technologies are presenting further opportunities for these models.

View Less

View More...

The Global Clinical Trials Connect 2019 strives to bring all the clinical research community and business people under one roof to share their ideas and conduct a collaborated research.
 

Clinical research is the hallmark of this conference and involves various disciplines including pre-clinical research and conduct of clinical trials. The Pharmaceutical industry is constantly evolving and new clinical studies, technologies and advancements in care and treatments have increased the efficiency and at the same time are facing difficulty in clinical trial operations in today’s research landscape. There are vast data collected across clinical trial process, the standardization of these data will turn into an opportunity for companies to trap the information and raise clinical trial design, patient recruitment, monitoring insights and augment decision-making. One response to this can be CROs and pharmaceutical companies can together work on diverse and varied clinical trial activities, also in near future we require joint effort for fulfilling outsourcing requirements and providing effective clinical trials.

View Less

View More...

After the implementation deadline of the European Falsified Medicines Directive, our 7th Annual Pharma Packaging and Labelling Forum will take place to discuss the first impressions of the regulation. Participants will be able to meet the newest technologies of the industry such as Smart Bar Code,Internet of Things, Virtual Reality and many others.

Furthermore we will discuss topics as track and trace and its update guidance, child safe packaging and solutions for the elderly generation. Our expert speakers will give an insight into artwork management and how to manage artwork changes efficiently. During the 2 days program we will have many interactive sessions as round table and panel discussions about how to keep Europe harmonized and first steps after implementation of the serialization directive. You will have the chance to get to know more about EU anti-counterfeit activities and where are the weaknesses of the current system. Join us on 9th and 10th of May in the historical city of Prague.

View Less

View Less

View More...

As the largest expo focusing on the natural health and nutrition in Asia. NHNE helps the global manufacturer of health food and nutrition to promote brand and develop business channels in China. With over 120,000 distributors and retailers, it's been the best platform for participants to search new products and get deep insight into the market.

 

View Less

View More...

The SMi Group is delighted to announce it's 19th Annual Pain Therapeutics conference which will be held in London on the 13th and 14th May 2019.

 

The global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, postsurgical pain, arthritis, and fibromyalgia, is driving growth.

 

Join Europe's leading Pain Therapeutics Conference which will explore the cutting edge research of novel therapeutic targets in the pipeline of leading pharmaceutical companies and discuss solutions for the challenges of clinical trial design and conduct.

 

New case studies and regulatory perspectives will bring together the challenges and successes of both pre-clinical and clinical development to equip you with the necessary knowledge to advance the pain therapeutic industry.

View Less

View More...

SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.

 

The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.

 

The event will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimize risk and advanced manufacturing processes. In addition, the conference aims to guide attendees through novel regulatory updates for each stage of HPAPI development.

View Less

View More...

China International Medicinal Equipment Fair (CMEF), launched in 1979, is held twice annually – spring and autumn. After over 38 years of continuous innovation and self-improvement, CMEF has become the largest fair of medical devices, related products and services in the Asia-Pacific region. The fair widely covers 15,000 products such as medical imaging, IVD equipment and reagent, medical electronics, medical optics, first aid, rehabilitation devices, nursing, telemedicine, wearable devices and outsourcing services, and it serves the entire value chain of medical devices from the source to the end in a direct and all-round way. At each fair, almost 4,200 medical device manufacturers from over 28 countries, and about 120,000 visitors and buyers who are government procurement agencies, hospital buyers and dealers from over 100 countries and regions gather in CMEF for trading and exchanges; With in-depth professional development of the exhibition, CMEF has initiated conference forums and established a series of sub-brands in medical field including CMEF Imaging, CMEF IVD and ICMD. Now CMEF has become the largest professional procurement and trade platform of the medical industry, the best corporate image release ground as well as a professional information distributing center and an academic, technical exchanging platform.

View Less

View More...

Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies

Over 20 case studies and presentations demonstrating the latest synthetic biology tools and their therapeutic applications

Join Oxford Global at the 5th Annual Single Cell Analysis USA Congress 2019 to discuss the future of this rapidly evolving field with key innovators from Pharma, Healthcare and Academia!

Our 3 interactive streams will cover:

    Day 1 Stream 3 – Single Cell ‘Omics Analysis: Current and Emerging Tools
    Day 2 Stream 2 – Translation to Diagnostic and Therapeutic Applications
    Day 2 Stream 3 – Single Cell Analysis: Emerging Trends and Technologies in Single Cell Analysis

View Less

View More...

Join Oxford Global at the 5th Annual NGS & Clinical Diagnostics USA Congress 2019 to discuss the future of sequencing with key innovators from Pharma, Healthcare and Academia!

Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies

20+ case studies and presentations covering multiple therapeutic areas such as oncology, immunotherapy, autoimmune disease and CNS disorders, this congress will focus on the latest technological developments in WGS, long read sequencing and data analysis as well as looking at key areas such as biomarker development and liquid biopsy approaches

5th Annual Next Generation Sequencing Congress

    Day 1 Stream 1: Exploring Emerging Trends In NGS Data Analysis, NGS Application Strategies & NGS Technologies
    Day 1 Stream 2: Sequencing Applications In Precision Medicine, Biomarker Development And Clinical Diagnostics (Join stream with our co-located 5th Annual Single Cell Analysis Congress)
    Day 2 Stream 1 – NGS Applications In Healthcare & Therapeutic Developments

View Less

View More...

The Only Conference Covering Every Aspect of Getting Your Biosimilar to Market Faster, Cheaper and Easier

 

We know that the competition to get your biosimilar to market first is fierce - and it's only getting fiercer!  So it's never been more essential to perfect your market strategy - ensuring it's  taking into consideration global regulations and healthcare systems, boosting stakeholder confidence and pricing.

 

Over 3 days of expert case-study presentations, you'll get to listen to insights that will help you to tailor your commercial strategy to penetrate both established and emerging markets.

View Less

View More...

Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies

Over 20 case studies and presentations demonstrating the latest synthetic biology tools and their therapeutic applications.

4 interactive streams focusing on:

•   Genome Editing Technologies & Techniques
•   Therapeutic Applications of Genome Editing
•   Drug Discovery & Development Applications
•  Transgenic Genome Editing – New for 2019

 

View Less

View More...

Over 600 senior-level delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies

Over 20 case studies and presentations demonstrating the latest synthetic biology tools and their therapeutic applications.

Including 2 interactive streams:

•   Synthetic Biology – Tool Development
•   Synthetic Biology – Applications

 

View Less

View More...

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focussing on the key issues in early and late stage cell line development, 3D cell culture applications, bioprocessing as well as AAV-based gene therapy manufacturing

4 interactive streams:

    Cell Line Development: Early Cell Culture & Cell Line Development
    Process Development: Upstream Bioprocessing and Analytics
    Cell Line Development: Concerns, Applications, Stability, Data & Assay Data Development
    Cell & Gene Therapy-Based Bioprocessing & Manufacturing Strategies

View Less

View More...

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 20 presentations, case studies and panel discussions focussing on the key issues in cell & gene therapy development, commercialisation, market access and clinical trial updates

2 interactive streams:

    Bringing Pre-Clinical Cellular & Gene Therapies to Patients: Development, Commercialisation, Market Access, Future Outlook
    Cell & Gene Therapy Development and Clinical Trials

View Less

View Less

View More...

The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.

 

The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

 

Injectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volume. Self-administrative, connected, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices.

View Less

View More...

Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure.  In 2014, 8.5% of adults aged 18 years and older had diabetes. In 2015, diabetes was the direct cause of 1.6 million deaths and in 2012 high blood glucose was the cause of another 2.2 million deaths.

 

Hypertension also known as high blood pressure, is a  long-term medical condition in which the blood pressure in the arteries is persistently elevated.Hypertension is a condition that’s often present in people with type 2 diabetes. It’s unknown why there’s such a significant correlation between the two diseases. It’s believed that obesity, a diet high in fat and sodium, and inactivity contribute to both conditions.

View Less

View More...

PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders, or rub elbows with pioneers across the globe. London is all set for an amazing event as PULSUS proudly presents the"4th World Biotechnology Congress"slated on May 20-21, 2019 at London,UK.

 

PULSUS cordially welcome researchers, academicians, students and business professionals in the field of Biotechnology from around the world to participate in the upcoming Biotechnology 2019. The meeting for this year will revolve around the theme “A Scientific Extravaganza for the Innovations and development of research in Biotechnology” thus relaying the most cutting-edge findings in the field of Biotechnology Research. The two-day meeting is going to be an event to look forward to for its enlightening symposiums & workshops from established experts of the field, exceptional keynote sessions directed by the best in the business. It will also prove to be a brilliant open door for the representatives from Universities and Institutes to cooperate with the world class researchers and an outstanding opportunity for businesses keen at expanding their global market reach. Interested individuals can confirm their participation by registering for the conference along with their colleagues. Register soon and avail exciting early bird discounts.

View Less

View More...

Over 300 delegates from global pharmaceutical organisations, leading biotechnology companies and world renowned academic institutions

Over 50 presentations and case studies focusing on the key developments in Immuno-Oncology from early discovery through to the clinic

Featuring the following main themes:

    Discovery of Immuno-Oncology Therapies
    Preclinical Development – Screening, Assays and Modelling in Immuno-Oncology
    Translational Immuno-Oncology
    Precision Medicine and Personalised Therapy
    Genomics in Cancer Immunotherapy
    Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials

View Less

View Less

View More...

12th International Conference on Pharmaceutical Chemistry during May 20-21, 2019 at Berlin, Germany.  The conference emphasizes the theme “Exploring the Challenges in Pharmaceutical Chemistry & Process of Drug Discovery for the Future”. Pharmaceutical Chemistry Conference provides an international dais for Scientists and Pharmaceutical Chemistry professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences. Pharmaceutical Chemistry and Analytical Chemistry together make an eminent growth in the Pharmacy or Medical industry. Knowledge of the concepts of drug metabolism is useful in both the design of new drugs and the improvement of existing drugs. Thus it affects the living life in an effective way. This is the platform where you can exchange your ideas and learn novel concepts related to your field from the international speakers as well as the professionals participating in this symposium. We want to take every individual related to this field either to learn or share your experience in this field and improve your connections from the entire globe. It’s important to share knowledge with others due to newly generated problem. For that they need a platform to share their knowledge. We could say we create a golden opportunity for those people expose their knowledge through this Pharma Chemistry Meeting.

View Less

View More...

The dermatology space continues to strive in therapeutic innovation; driven by a transformative evolution in the understanding of the pathophysiology of skin diseases and the availability of treatment options for conditions that affect the lives of millions of patients worldwide. This vast environment of opportunity is driving leading organisations and experts to focus on innovating and bringing better and more efficient therapies to market.

 

Expanding on two editions of the annual US meeting, the Dermatology Drug Development series makes its debut in Frankfurt to provide the European dermatology community with an end-to-end industry forum dedicated to bringing new dermatological medicines to market.

 

Join this growing platform to gain exclusive insights from experts, collaboratively tackle challenges being faced to develop these drugs and uncover the details behind the latest developments in this space.

View Less

View More...

Digital healthcare is transforming medicine and revolutionising global health systems. Technology giants and start-ups are already disrupting healthcare in many areas to create a patient centric ecosystem. Thus, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies to be ahead of the game and make most use of the healthcare technologies, resources and tools that integrate with patient’s lifestyle and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases to improve success rates and get new drugs to patients faster.
 

The deployment of technology is now increasingly dominant in pharmaceutical R&D; the enhancements in data management and data integration are providing improvements to both the speed and quality of many clinical trial processes. The combination of AI, big data and IoT technologies will create new innovations and other eminent technologies like cloud computing, augmented reality, virtual reality, 3D printing and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.
 
Therefore, this upcoming conference 3rd Annual Digi-Tech Pharma, will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of Digital Pharma IT. Also, to stay updated on the latest trends in digital, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the Pharmaceutical Conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.
 

It gives us a great pleasure to welcoming you to this international 3rd Annual Digi-Tech Pharma conference.

View Less

View More...

FCE Pharma is the main marketing, communications and sales platform for the pharmaceutical industry. The show plays a fundamental role in the industry's growth. In addition to bringing together launches, trends, new technology for the pharmaceutical industry, products and services, the event also provides quality content, exchange of experiences with specialized professionals, case studies and participation in conferences and talks. It is an investment with a short- and long-term financial return and is recommended for companies looking to prospect new customers and raise their profile in the market.

View Less

View Less

View More...

The excitement and investment for CRISPR is ever amplifying as it infiltrates drug discovery platforms worldwide. Join 5th Precision CRISPR Genome Editing Congress as we focus on the delivery of more precise, efficient and safer genome editing to optimize drug discovery, functional screening and CRISPR-based cell and gene therapies.

 

Tackling delivery, safety, precision, and efficiency best practice, further optimize your drug discovery, functional screening, and translation of CRISPR-based cell and gene therapy into the clinic. With the first wave of CRISPR based therapeutic clinical trials firmly underway, the 5th Precision CRISPR Genome Editing Congress is perfectly timed to demonstrate the growing applications of CRISPR and unique approaches to gene therapy.

 

With 100+ thought leaders converging at the 5th Precision CRISPR Genome Editing Congress this will surely be an unrivaled opportunity for you to access the latest clinical data, define protocol best practice and gain insight on the future trends of CRISPR as the genetic engineering landscape rapidly continues to evolve.

View Less

View Less

View More...

The drug development process as we know it is being transformed through digitalisation.

 

Increased computing power is allowing new insights through data mining, simulation and artificial intelligence.

 

Work processes that so far have been handled by humans are starting to be automated, e.g. through robotics processes. All done to minimise cost in the drug development process in form of time and ressources.

 

While the shorter-term benefits of digitalisation are gradually becoming tangible, there are also longer-term aspirations to transform the entire operating model of clinical research. Consortia like TransCelerate Biopharma, Clinical Trials Transformation Initiative (CTTI) and Innovative Medicines Initiative (IMI) to name a few are putting digitalisation high on the agenda. Digitalisation in form of Shared Investigator Platform, eSource, Digital Data Flow, Technology Enabled Common Protocol Template and Blockchain are seen as major initiatives pulling in big pharma, academic institutions and regulators to jointly transform the way we work – and ultimately change pharma’s role in the broader healthcare perspective.

View Less

View Less

View Less

View More...

10th Annual Clinical Trials Summit 2019 is inspiring keynote presentations, plenary talks and panel discussions. This will discuss most recent techniques, developments, novel strategies and various disciplines involved in drug discovery, clinical research, patient centricity, clinical site & supply management, medical imaging, data management and outsourcing in clinical trials. It will educate healthcare and clinical researcher professionals about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials. It also promotes better understanding by the general public about the importance of clinical trials in prevention, diagnosis and treatment of diseases.

 

We have been delivering the conference through close collaboration with the industry for nearly a decade. For the 2019 edition, the agenda includes a host of new and exciting features

 

Take a chance and make it count in your Professional life. Attend the 10th Annual Clinical Trials Summit 2019 Conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level.

 

We look forward to see you personally at our esteemed event.

View Less

View Less

View More...

After a successful conference of International Conference & B2B on Pharma Research and Development,Pharmaceutical Conferencesteamcordially invites participants from all over the world to attend 2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry(Pharma Research 2019)slated on May 30-31, 2019 at Orlando, USA.ThisPharma Research 2019 conference includes a wide range of Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops, Exhibitions and Career development programs. We cordially welcome all the eminent Professors, researchers, students, and delegates to take part in this upcoming event to witness invaluable scientific discussions and contribute to the future innovations in the field ofPharma Research and Development

View Less

View More...

The 5th Global Endotoxin Testing Summit will bring together the community to explore the most pertinent topics in the industry. Experts from the pharma industry, key opinion leaders, end-users and regulators will gather to share updates on hot topics and to learn from the practical experience of others. In collaboration with the Ecological Research and Development Group, a non-profit wildlife conservation organization whose primary focus is the conservation of the world's four horseshoe crab species, Summit attendees will travel to a Horseshoe Crab Sanctuary Beach (Pickering Beach, DE) to gain hands-on insight into the natural environment of the crabs, and to save horseshoe crabs stranded on shore. Attendees have opportunity to learn more about the ancient species so important to our industry.

View Less

View Less

View More...

SMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019, in London, UK.

Lyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion. With up to a third of all FDA-approved parenterals and almost half of all injectables expected to be lyophilised in the near future, significant strides toward better standards and regulation are also anticipated to follow suit.

Despite being a relatively old process, lyophilisation continues to raise challenges in conjunction with ever changing biopharmaceutical products that carry their own set of inherent complexities. Join us along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science, materials characterisation, novel and alternative technologies, mathematical modelling and regulatory updates.

View Less

View More...

Antibiotics 2019 invites all the participants from all over the world to attend ‘6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance' to be held on June 03-04, 2019 London, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

 

We organize a series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

View Less

View Less

View More...

The legal basis for clinical research is changing rapidly and is driven in Europe and Germany by the EU legislation. On one hand there is the Clinical Trial Regulation EU 536/2014 and its national implementation which are suffering from some delays due to the EU portal, its database and the consequences of BREXIT. On the other hand, there is the more recently General Data Protection Regulation EU 2016/679 (GDPR) and its national implementation (Datenschutz-Grundverordnung, DSGVO), come into force in May 2018, affecting patient rights and data processing. Both legislations are causing to some degree a level of uncertainty.

 

The German e-Pharma day will examine the consequences of the new regulations from different viewpoints: from patient rights to data protection in clinical research with a special focus on the national adaptations.

 

Evolutions in technology and risk management processes offer new opportunities to increase efficiency and focus on relevant activities. The new ICH GCP Guidance Integrated Addendum (March 2018) provides a unified standard to facilitate the mutual acceptance of data from clinical trials.

View Less

View More...

2nd International Pharmaceutical Conference and Expo welcomes you as our guest to the City of Baltimore, USA during June 05-07, 2019. iPharma 2019 includes nearly every permutation of knowledge, innovation, technology and networking; and has an objective of creating an international forum for academicians, practitioners and business professionals to discuss the soundest issues related to Pharma, Biotech and Health Care.

This program provides three days of robust discussions in the field of Drug Discovery and Development, Pharmacovigilance and Drug Safety, Novel Drug Delivery Systems and Drug therapy, Pharmaceutical Nanotechnology, Drug Regulatory Affairs, Pharmacology, Neuropharmacology, Nutraceuticals, Pharma Marketing, Orphan and Rare Disease and more.

View Less

View More...

SMi proudly presents the 3rd Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA, on the 5th and 6th of June 2019.
The pharmaceutical microbiology field is an ever-present constant in almost all areas of pharmaceuticals. We are experiencing a period of rapid change, with new regulatory considerations to implement into our environmental monitoring programmes,  new technologies to improve processes and novel validation techniques.

Join us as we delve into the current evolving issues facing this industry, such as: risk-based approaches to aseptic processing, methods of contamination prevention, creating risk-based environmental monitoring programmes, water monitoring and treatment.

View Less

View More...

This conference will deal with the legal, regulatory and scientific requirements of Signal Management including updates of Safety Relevant Information with and without respect to EVDAS. Different approaches to fulfil the obligations and to substantially increase patient´s safety will be presented and discussed. Associated topics like SDEAs and GDPR in Signal Management are also covered.

 

View Less

View More...

ME Conferences invites all the participants from all over the world to attend 2nd International Conference on Addiction & Psychiatry which is going to be held during June 10-11, 2019 in Helsinki, Finland. The main theme of the conference is “Conceptualizing the new discoveries and advanced technologies for the treatment of addiction”.

 

Addiction 2019 Conference includes Oral talks, Poster presentations, and Keynote presentations, Workshop, Symposia and Exhibitions. The conference invites the academicians, Scientists, top Universities, Researchers, Health care professionals, Psychologists, Addiction Specialists, Industries, Students, Business peoples and Young researchers over the globe providing a better platform, where they can show their novel research and contributions in the field of Addiction and Psychiatry.

 

We assure that international Addiction conference 2019 will be an open access network for the peoples to trade thoughts and a typical vision for future research. Hence we are very pleased to invite you to attend Addiction 2019 to share and get novel research ideas.

View Less

View More...

Medicinal Chemistry 2019  which is the primordial chemistry conferences serves as a global platform to discuss and learn about Medicinal Chemistry, Pharmaceutical Sciences, Drug Design and Drug Development, CADD (Computer Aided Drug Design), Bioorganic and Medicinal Chemistry, Pharmacology and toxicology, Anticancer agents in Medicinal Chemistry, Analytical Chemistry, Pharmaceutical Industry, Organic Chemistry, Clinical Pharmacology,  Evolution of Organic and Medicinal Chemistry in Pharma,  Organic and Medicinal Chemistry Technologies for Drug Discovery, QSAR (Quantitative Structure-Activity Relationship) Fragment-Based Drug Design, Applications of Organic and Medicinal Chemistry in Drug Discovery, Market Dynamics, Conclusions and Future Trends, Medicinal Plants

View Less

View More...

The 13th Partnering With ACOs & IDNs Summit will serve as an educational environment for participants to learn proven strategies and vital information that will further partnerships with ACOs and IDNs. This event provides attendees with a forum to better understand how to navigate the healthcare landscape, contract with, and sell to these evolving systems.

 

Given the uncertainty of the future of ACOs, this is the must-attend time to attend the summit. This event will focus on creating strategic partnerships with health systems through collaborative discussions centered on patient outcomes and adherence.

View Less

View Less

View Less

View Less

View More...

The development of the Biosimilars market is growing exponentially with the industry forecast to be worth $25 billion by 2020. The global biosimilar market is estimated to register a CAGR of 39.53% over the forecast period of 2017-2023. The growth in the market may be attributed to the cost-effectiveness of the biosimilars when compared to reference biologics coupled with the patent expiration of the many blockbuster biologic drugs. By 2018, biologics worth more than US$68 billion annual sales will lose patent protection. Due to structural complexity of the biosimilar drugs, multi-layered manufacturing and risk of immunogenicity, separate regulatory pathways have been drafted to introduce them into the market. Increasing investment by the companies for the development of biosimilars will also be the key factor driving the market.

 

Our 13th Biosimilars Congregation 2019 will provide insight into the current state of play in the EU and stimulate debate, in a multi-stakeholder setting, on the vital role of biosimilar medicines in the sustainability of healthcare systems. Beyond a comprehensive outlook of key European market access policies,  our speakers will outline the key recent developments in regulatory science and regulatory policy in the EU and other international jurisdictions. Special emphasis will be placed on strengthening the link between regulators and medical communities as an essential basis for greater understanding and acceptance of biosimilar medicines. This Biosimilars conference will focus on multiple aspects of Biosimilar product development to successfully deliver safe, Biosimilar products to the market place. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding Biosimilars. This event will provide an important platform for Biosimilars stakeholders to discuss and share best practices in furthering Biosimilars development.

 

It gives me great pleasure in welcoming all of you to the Virtue Insight’s 13th Biosimilars and Congregation 2019.

View Less

View More...

300 delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 55 presentations, case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry

20th Annual Drug Discovery Summit

    Day 1 Stream 1: Drug Discovery Innovation and Strategies
    Day 1 Stream 2: Successful Phenotypic Drug Discovery and Other High Content Screening Tools
    Day 2 Stream 1:
        PART 1: Biologics and Small Molecule Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
        PART 2: NEW FOR 2019! The Role of the Microbiome and Natural Products In Drug Discovery
    Day 2 Stream 2:
        PART 1: Lead Identification and Discovery ADMET
        PART 2: Innovation in Genome and Cell Based Drug Discovery

View Less

View Less

View More...

Over 400 senior discovery attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

Over 18 presentations and case studies focusing on the latest trends and technologies in Bispecifics discovery as well as the considerations for immunogenicity, safety, CMC, biomarkers in bringing Bispecific in clinic. The congress also explores the role of Bispecific antibodies in paving the next wave of biotherapeutics.

Including 2 interactive streams:

    Bispecific Discovery, Therapeutic Development and Developability Considerations

    Preclinical Development, Translation and Clinical Development in Bispecific Antibodies

View Less

View More...

Over 150 delegates from global pharmaceutical organisations, emerging biotech companies and established academic institutions

Over 20 presentations and case studies on the latest discoveries in CNS along with patient stratification and biomarker development for neuroscience

Including two interactive streams:

•   Drug Discovery Strategies in CNS

 

•   Translation, Stratification and Precision Medicine In Neuroscience

 

View Less

View More...

Developed with Remegen, Eisai and Regeneron the 2nd World ADC Asia is the definite ADC forum which curates the leading companies from Asia and the rest of the world focused on antibody-drug conjugate development.

 

Across 3 days, with 120+ ADC experts, this comprehensive antibody-drug conjugates conference will enable you to propel your ADC pipeline into clinical development. You’ll explore lessons learned from working with regulatory bodies, reviewing latest phase I clinical readouts and confidently optimize ADC CMC processes to improve your manufacturing programs. Not only will World ADC Asia delve into general antibody-drug conjugate challenges is will also focus on challenges and opportunities specific to development within Asia.

 

Attend World ADC Asia to network with potential collaborators, foster new connections and further cement existing partnerships. This is the only ADC focused conference that will bring together all the key players within antibody-drug conjugates in Asia.

View Less

View More...

Pharmacovigilance is at the center of the health ecosystem, made up of alliances, partnerships and business cross-contaminations. Therefore, our focus during this conference will be on the importance of collaboration and communication at local, regional and international levels, to ensure pharmacovigilance delivers its full benefits.

 

View Less